Found: 23
Select item for more details and to access through your institution.
The importance of correct assignment of CYP2B6 genetic variants with respect to cyclophosphamide metabolizer status.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 4, p. 383, doi. 10.1002/ajh.21987
- By:
- Publication type:
- Article
Validating TDP1 as an Inhibition Target for the Development of Chemosensitizers for Camptothecin-Based Chemotherapy Drugs.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 541, doi. 10.1007/s40487-021-00158-0
- By:
- Publication type:
- Article
Unravelling the role of SNM1 in the DNA repair system of T rypanosoma brucei.
- Published in:
- Molecular Microbiology, 2015, v. 96, n. 4, p. 827, doi. 10.1111/mmi.12973
- By:
- Publication type:
- Article
Ethnic disparity in clozapine dosing and cardiotoxicity in New Zealand.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Testing for dihydropyrimidine dehydrogenase deficiency in New Zealand to improve the safe use of 5-fluorouracil and capecitabine in cancer patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Testing for dihydropyrimidine dehydrogenase deficiency in New Zealand to improve the safe use of 5-fluorouracil and capecitabine in cancer patients.
- Published in:
- New Zealand Medical Journal, 2021, v. 134, n. 1545, p. 106
- By:
- Publication type:
- Article
Metabolomic analysis reveals differences in urinary excretion of kiwifruit-derived metabolites in a mouse model of inflammatory bowel disease.
- Published in:
- Molecular Nutrition & Food Research, 2011, v. 55, n. 12, p. 1900, doi. 10.1002/mnfr.201100302
- By:
- Publication type:
- Article
Single-nucleotide polymorphisms and copy number variations of the FCGR2A and FCGR3A genes in healthy Japanese subjects.
- Published in:
- Biomedical Reports, 2014, v. 2, n. 2, p. 265, doi. 10.3892/br.2013.210
- By:
- Publication type:
- Article
A higher throughput assay for quantification of melphalan-induced DNA damage in peripheral blood mononuclear cells.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-55161-3
- By:
- Publication type:
- Article
Hepatic cytochrome P450 CYP2C activity in psoriasis: studies using proguanil as a probe compound: Investigative reports.
- Published in:
- Acta Dermato-Venereologica, 1998, v. 78, n. 2, p. 81, doi. 10.1080/000155598433359
- By:
- Publication type:
- Article
CYP2C19 and CYP2D6 genotypes in Pacific peoples.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 82, n. 5, p. 1303, doi. 10.1111/bcp.13045
- By:
- Publication type:
- Article
The combined impact of CYP2C19 and CYP2B6 pharmacogenetics on cyclophosphamide bioactivation N. A. Helsby et al. Cyclophosphamide activation by CYP2C19 and CYP2B6.
- Published in:
- British Journal of Clinical Pharmacology, 2010, v. 70, n. 6, p. 844, doi. 10.1111/j.1365-2125.2010.03789.x
- By:
- Publication type:
- Article
Omeprazole-induced acute interstitial nephritis is not related to CYP2C19 genotype or CYP2C19 phenotype.
- Published in:
- British Journal of Clinical Pharmacology, 2010, v. 69, n. 5, p. 516, doi. 10.1111/j.1365-2125.2010.03623.x
- By:
- Publication type:
- Article
A case–control study to assess the ability of the thymine challenge test to predict patients with severe to life threatening fluoropyrimidine‐induced gastrointestinal toxicity.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 1, p. 155, doi. 10.1111/bcp.14153
- By:
- Publication type:
- Article
The Concise Guide to PHARMACOLOGY 2023/24: Enzymes.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 2, p. S289, doi. 10.1111/bph.16181
- By:
- Publication type:
- Article
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Re-thinking the possible interaction between proton pump inhibitors and capecitabine.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A systematic review of inter-individual differences in the DNA repair processes involved in melphalan monoadduct repair in relation to treatment outcomes.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 5, p. 755, doi. 10.1007/s00280-021-04340-z
- By:
- Publication type:
- Article
Cyclophosphamide bioactivation pharmacogenetics in breast cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 533, doi. 10.1007/s00280-021-04307-0
- By:
- Publication type:
- Article
Comparison of a thymine challenge test and endogenous uracil-dihydrouracil levels for assessment of fluoropyrimidine toxicity risk.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A simple ex vivo bioassay for 5-FU transport into healthy buccal mucosal cells.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Association between the low-dose irinotecan regimen-induced occurrence of grade 4 neutropenia and genetic variants of UGT1A1 in patients with gynecological cancers.
- Published in:
- Oncology Letters, 2014, v. 7, n. 6, p. 2035, doi. 10.3892/ol.2014.2046
- By:
- Publication type:
- Article
Cross-Comparison of Exome Analysis, Next-Generation Sequencing of Amplicons, and the iPLEX ADME PGx Panel for Pharmacogenomic Profiling.
- Published in:
- Frontiers in Pharmacology, 2016, p. 1, doi. 10.3389/fphar.2016.00001
- By:
- Publication type:
- Article